A detailed history of Payne Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Payne Capital Management, LLC holds 13,787 shares of MRK stock, worth $1.28 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
13,787
Previous 4,105 235.86%
Holding current value
$1.28 Million
Previous $325 Million 256.12%
% of portfolio
0.37%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 01, 2025

BUY
$77.6 - $87.37 $751,323 - $845,916
9,682 Added 235.86%
13,787 $1.16 Billion
Q2 2025

Nov 25, 2025

BUY
$73.47 - $87.12 $115,788 - $137,301
1,576 Added 62.32%
4,105 $325 Million
Q1 2025

Nov 25, 2025

SELL
$83.01 - $101.02 $46,651 - $56,773
-562 Reduced 18.18%
2,529 $227 Million
Q4 2024

Nov 25, 2025

BUY
$96.31 - $114.76 $297,694 - $354,723
3,091 New
3,091 $307 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Payne Capital Management, LLC Portfolio

Follow Payne Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payne Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Payne Capital Management, LLC with notifications on news.